Effectiveness of Education, Medication Adjustment and Telemonitoring in Reducing Diabetes Complications During Ramadan

Diabetes Mellitus Clinical Trial

Official title:

Effectiveness of Diabetes Education and Medication Adjustment With Telemonitoring Intervention in Reducing Diabetes Complications During Ramadan Fasting - a Randomized Control Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06033872
• Other study ID #: 2019/2888
• Status: Completed
• Phase: N/A
• Start date: January 25, 2021
• Est. completion date: May 31, 2022

Study information

• Verified date: September 2023
• Source: Sengkang General Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Introduction Diabetes is a global emergency with detrimental clinical and financial consequences. Poorly managed diabetes leads to a myriad of serious complications, especially cardiovascular and infectious complications, with consequent increased cost and mortality rate. For Muslims in particular, the annual fasting month of Ramadan is one such period when diabetes control is essential. Adequate adjustments in diabetes management need to be made in line with the allowed meal times to avoid the risk of diabetes complications during Ramadan. Objective Investigators aim to investigate the effectiveness of focused diabetes education and medication adjustment with telemonitoring to reduce diabetes complications during Ramadan fasting as well as to assess the cost-effectiveness of this intervention for Muslims with diabetes in Singapore. Methodology In a parallel group randomized controlled trial, investigators aim to recruit 100 adults with diabetes who are able to fast at least 15 days in Ramadan. Participants will be randomized to the intervention group comprising of focused diabetes education, medication adjustment and telemonitoring, and control group receiving standard care. Participants will be followed up during Ramadan. The primary outcome is the incidence of hypoglycemia in Ramadan. The secondary outcomes are (i) incidence of other diabetes complications in Ramadan episodes including hyperglycemia, episodes of acute infections, attendances in clinic and emergency department and that of hospital admission, and (ii) cost-effectiveness of the intervention. Clinical Significance The study enables investigators to evaluate focused pre-Ramadan diabetes education and medication adjustment with tele-monitoring as a means to reduce the markedly increased risk of diabetes complications for a large population during the fasting month, with potential for increased cost-effectiveness through reducing unscheduled attendances at clinic and hospital.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 79
• Est. completion date: May 31, 2022
• Est. primary completion date: September 1, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 21 Years to 100 Years

Eligibility

Inclusion Criteria:

-

Participants must meet all of the inclusion criteria to participate in this study:

1. Adults aged at least 21 years old,

2. Able to fast at least 15 days in Ramadan based on experience of fasting in previous year's Ramadan,

3. Known physician-diagnosed diabetes mellitus (DM) based on the following criteria before starting treatment a. Symptoms of polyuria, polydipsia and unexplained weight loss with i. fasting glucose = 7.0mmol/l or ii. random plasma glucose = 11.1 mmol/l or iii. 2-hour post 75g oral glucose challenge test plasma glucose = 11.1 mmol/l b. Absence of symptoms of polyuria, polydipsia and unexplained weight loss with the following tests done twice showing the values i. fasting glucose = 7.0mmol/l or ii. random plasma glucose = 11.1 mmol/l or iii. 2-hour post 75g oral glucose challenge test plasma glucose = 11.1 mmol/l

4. Performed laboratory tests as per standard care : serum glycated hemoglobin A1c (HbA1c) level, blood Low Density Lipoprotein-Cholesterol, blood triglyceride level, blood High Density Lipoprotein-Cholesterol, blood Total Cholesterol and serum creatinine

5. Most recent HbA1c level was >7.0% (>53mmol/mol)

6. Ability to give informed consent,

7. Ability to perform weekly recordings in the diary,

8. Able to use and owns a mobile phone for recordings on mobile application

9. Should have had DM-related clinic visits or hospitalization in the past 10 months. Exclusion Criteria: - Meeting any of the exclusion criteria at baseline will exclude participants from

participation:

1. Severe diabetes complications including end-stage renal failure, severe hypoglycemia and hyperglycemic crises within the last 1 month negating ability to fast,

2. Pregnancy.

Related Conditions & MeSH terms

• Diabetes Complications
• Diabetes Mellitus
• Fasting

Intervention

Combination Product:
• Focused education, medication adjustment and telemonitoring
Focused diabetes education session for Ramadan fasting Participants will be taught to record Meal plans Physical activities Blood glucose monitoring, and Monitoring for diabetes complications. Then perform a trial fasting day prior to Ramadan when control is not optimal or medication with risk of hypoglycemia. Medication adjustment for Ramadan fasting Participants will be provided regimen modified for Ramadan fasting. Telemonitoring Participants will be taught to perform blood glucose monitoring 4 times daily using a glucometer and upload recordings of glucose levels onto the data software.

Locations

Country	Name	City	State
Singapore	Sengkang General Hospital	Singapore

Sponsors (3)

Lead Sponsor	Collaborator
Sengkang General Hospital	Singapore Clinical Research Institute, SingHealth Polyclinics

Country where clinical trial is conducted

Singapore, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	a. To compare the first incidence rate of hypoglycemia or severe hypoglycemia between intervention and control groups in Ramadan		30 day
Secondary	i. To compare the first incidence rate of hypoglycemia or severe hypoglycemia between intervention and control groups in Ramadan when compared to before and after Ramadan		12 weeks
Secondary	ii. To compare the first incidence rate of complications in Ramadan when compared to before and after 1. Hyperglycemia and crises 2. Acute infections, clinic and emergency department attendances and hospital admissions		12 weeks
Secondary	Health-related Quality-of-Life using European Quality of Life Five Dimensions (EQ-5D) - to provide a summary of index value of health and health change, cost-utility calculation.	Five dimensions are mobility, self-care, usual activities, pain or discomfort and anxiety or depression. Scored health as 0 to 100 where 0 is worst and 100 is best	17 weeks
Secondary	Healthcare utilizations costs - Medical services, drugs and devices utilized, outpatient and inpatient visits, cost of intervention sessions, telemonitoring and equipment, indirect costs related to health care utilisation, and caregiver costs.		17 weeks